O’Melveny’s Cantor’s Representation of UBS in Dismissal of Counterclaims Featured in Law360

February 03, 2012

O’Melveny & Myers partner Daniel L. Cantor’s representation of UBS Securities LLC was featured in the February 2, 2012 Law360 article “Angioblast Loses Contract Counterclaims Against UBS.” According to the article, a New York state judge dismissed stem cell research firm Angioblast Systems Inc.'s allegations that UBS is not entitled to US$7.8 million in transaction fees related to an agreement to raise capital for a merger. The case is UBS Securities LLC v. Angioblast Systems Inc., case number 650062/2011, in the Supreme Court of the State of New York, County of New York.


Cantor is a member of O’Melveny’s Securities Litigation Practice and resident in the Firm’s New York office.